We do not know if medicinal and non-medicinal treatments help reduce impulsive-compulsive behaviors in people with Parkinson's disease because the currently available evidence is limited and uncertain ...
Myasthenia gravis is a rare disease where the immune system attacks the communication between nerves and muscles, causing weakness. It often affects the muscles used for eye movement, facial ...
Simple hysterectomy may result in little to no difference in the number of deaths from any cause, life expectancy after treatment, deaths from cancer, cancer-free period after treatment, or the rate ...
• Blood pressure-lowering medications lower the chance of death and probably reduce heart attacks and strokes in people with hypertension (high blood pressure) 60 years of age or older. • There may be ...
Doctors need reliable ways to predict seizure risk after a first unprovoked seizure, to help guide diagnosis and treatment. This is especially important because a diagnosis of epilepsy can now be made ...
Due to a lack of robust evidence, the benefits and risks of adding chemotherapy directly into the abdominal cavity (intraperitoneal chemotherapy, or IPC) for stomach cancer are unclear.
We did not find enough good‐quality evidence to draw reliable conclusions about the benefits and risks of different work-break interventions for preventing musculoskeletal symptoms and disorders ...
Our Handbooks describe the process of preparing and maintaining diverse types of systematic reviews. Handbooks are updated regularly to reflect advances in systematic review methods and in response to ...
Plain language summaries are summaries of the health evidence that Cochrane produces, written in a way that everyone can understand. At Cochrane, we write systematic reviews of research into human ...
Help us break the language barrier to informed health decisions We translate Cochrane evidence to help people around the world make evidence-informed health decisions. Only 6% of people in the world ...
Cochrane Evidence Essentials is an introduction to evidence-based medicine, clinical trials and Cochrane evidence. It is designed for patients and the public, policy makers and members of healthcare ...
To speak to the a member of the Cochrane Collaboration press office: If you would like to be added to our mailing lists for press releases about new Cochrane reviews, just send us an email. We can ...